S&P 500   4,486.46
DOW   35,258.61
QQQ   372.65
S&P 500   4,486.46
DOW   35,258.61
QQQ   372.65
S&P 500   4,486.46
DOW   35,258.61
QQQ   372.65
S&P 500   4,486.46
DOW   35,258.61
QQQ   372.65

MedX Health Stock Forecast, Price & News

0.00 (0.00 %)
(As of 10/18/2021 03:54 PM ET)
Today's Range
50-Day Range
52-Week Range
Volume30,000 shs
Average Volume239,546 shs
Market CapitalizationC$20.92 million
P/E RatioN/A
Dividend YieldN/A
30 days | 90 days | 365 days | Advanced Chart
Receive MDX News and Ratings via Email

Sign-up to receive the latest news and ratings for MedX Health and its competitors with MarketBeat's FREE daily newsletter.

About MedX Health

MedX Health Corp., a medical device and software company, develops, manufactures, and markets skin related screening tools and phototherapy devices for pain relief and tissue repair in Canada, the United States, and internationally. It offers SIAscopy, a medical device technology used to scan skin for suspicious moles and lesions; phototherapeutic medical devices, which use light energy in lower-level laser and LED to provide treatment for pain and tissue damage in the rehabilitation market; and SIAMETRICS, a research system used to assess treatment effectiveness of a variety of skin conditions, including burns. The company operates DermSecure telemedicine platform that enables the web-based operation of SIAscopy scanning technology and allows the company to deploy its technology in networks of third-party locations from which patients' mole and lesion scans can be connected to specialist physicians for remote assessment. In addition, it designs, manufactures, and distributes photobiomodulation therapeutic and dental lasers to provide drug-free and non-invasive treatment of tissue damage and pain. The company was incorporated in 1999 and is headquartered in Mississauga, Canada.


See More Headlines

Industry, Sector and Symbol

Scientific & Technical Instruments
Year Founded

Sales & Book Value

Annual Sales
Cash Flow
C$0.01 per share
Book Value
C($0.01) per share





Market Cap
C$20.92 million
Next Earnings Date
11/26/2021 (Estimated)
Not Optionable


Overall MarketRank

0.93 out of 5 stars

Analyst Opinion: 0.0Community Rank: 4.7Dividend Strength: 0.0Insider Behavior: 0.0Valuation: 0.0 5 -4 -3 -2 -1 -

MedX Health (CVE:MDX) Frequently Asked Questions

What stocks does MarketBeat like better than MedX Health?

Wall Street analysts have given MedX Health a "N/A" rating, but there may be better buying opportunities in the stock market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new stock ideas, but MedX Health wasn't one of them. MarketBeat thinks these five companies may be even better buys.
View MarketBeat's top stock picks here.

When is MedX Health's next earnings date?

MedX Health is scheduled to release its next quarterly earnings announcement on Friday, November 26th 2021.
View our earnings forecast for MedX Health

How has MedX Health's stock been impacted by Coronavirus (COVID-19)?

MedX Health's stock was trading at C$0.11 on March 11th, 2020 when Coronavirus (COVID-19) reached pandemic status according to the World Health Organization. Since then, MDX shares have increased by 4.5% and is now trading at C$0.12.
View which stocks have been most impacted by COVID-19

Who are MedX Health's key executives?

MedX Health's management team includes the following people:
  • Mr. Robert von der Porten B.A., M.B.A., MBA, BA, Chairman, Interim CEO & Pres
  • Mr. James H. Cooke, Chief Financial Officer
  • Mr. Louie Canitano, COO & MD of Light Therapy Products
  • Mr. Peter Holmes B.A., M.A, VP of Sales (Age 53)
  • Mr. Paul Karam, Sales and Marketing Director of Europe, Middle East & Africa
  • Dr. Daniel A. Kaute, Managing Director of Europe
  • Mr. Scott Naughton, Managing Director of US Operations
  • Mr. Mike Druhan, Pres of Dermatological Services & Products
  • Mr. Naman Demaghlatrous, Managing Director of EMEA
  • Mr. Sylvain Desjeans, Chief Revenue Officer

What other stocks do shareholders of MedX Health own?

What is MedX Health's stock symbol?

MedX Health trades on the Canadian Venture Exchange (CVE) under the ticker symbol "MDX."

How do I buy shares of MedX Health?

Shares of MDX and other Canadian stocks can be purchased through an online brokerage account. Popular online brokerages with access to the Canadian stock market include BMO InvestorLine, CIBC Investor's Edge, Desjardins Online Brokerage, HSBC InvestDirect, Laurentian Bank Discount Brokerage, National Bank Direct Brokerage, Qtrade Investor, Questrade, RBC Direct Investing, Scotia iTrade, TD Direct Investing, and Virtual Brokers.
Compare Top Brokerages Here.

What is MedX Health's stock price today?

One share of MDX stock can currently be purchased for approximately C$0.12.

How much money does MedX Health make?

MedX Health has a market capitalization of C$20.92 million and generates C$621,259.00 in revenue each year.

What is MedX Health's official website?

The official website for MedX Health is www.medxhealth.com.

Where are MedX Health's headquarters?

How can I contact MedX Health?

MedX Health's mailing address is 1495 Bonhill Rd Unit 1, MISSISSAUGA, ON L5T 1M2, Canada. The company can be reached via phone at +1-905-6704428.

This page was last updated on 10/19/2021 by MarketBeat.com Staff


Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms
Details Here
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research.